Automated Cell Culture - Market Insights, Competitive Landscape, and Market Forecast - 2030

The global automated cell culture market is estimated to grow at a CAGR of 7.17% during the forecast period from 2024 to 2030. The demand for Automated Cell Culture is primarily being boosted owing to the increasing funding for cell-based research, technological advancements in cell culture, and the growing focus on regenerative medicine, among others during the forecast period from 2024 to 2030.

Automated Cell Culture Market Dynamics:

One of the main drivers of the automated cell culture market is the increasing funding for cell based research around the world.

Cell culture is integral in developing biological products to combat diseases like cancer and cardiovascular ailments. Globally, significant R&D efforts, backed by both governmental and private entities, are focused on pioneering cell therapy solutions. For instance, CellVovant, a biotech firm affiliated with the University of Bristol, secured USD 9.55 million (GBP 7.6 million) in seed funding in January 2021 to accelerate the development of innovative stem cell therapies.

Moreover, collaborations between public and private sectors are driving advancements; examples include research funding from organizations like the Ovarian Cancer Research Alliance and the European Research Council for investigating stem cell-based treatments for various diseases. With increasing research and funding directed towards addressing autoimmune, neurological, and cardiovascular disorders, the cell therapy market is poised for significant expansion.

Thus, the above-mentioned facts illustrate the increasing funding for cell based research across the globe, which will lead to an increase in the demand for Automated Cell Culture, thereby propelling the Automated Cell Culture market growth during the forecast period of 2024 to 2030.

However, the high cost of cell biology research and data security issues may act as significant restraints that are expected to limit the growth of the automated cell culture market during the forecast period.

Automated Cell Culture Market Segment Analysis:

Automated Cell Culture market by Product Type (Systems and Consumables), Application (Drug Screening & Development, Biopharmaceutical Production, Tissue Engineering & Regenerative Medicine), End-User (Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Academic and Research Institutes, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the automated cell culture market, the systems category is estimated to amass a significant revenue share in the Automated Cell Culture market in 2023. This can be attributed to the various research applications offered by systems that are expected to increase the demand for the same.

Systems for automated cell culture are designed to streamline and expedite any cell culture process; as automated cell culture instruments perform the necessary duties to establish and maintain a cell culture mechanically, they are used in laboratories.

Automated cell culture systems can perform several activities, such as plating cultures, dilution of samples, continuous spinning of cultures in liquid culture, and well-depositing of cultures. Because automated cell culture systems can generate the best cell lines over the whole range of seeding, feeding, massaging, and cell multiplication, their popularity has grown. They help achieve high standards and criteria while reducing human error. The need for automated cell culture equipment is growing as high-throughput cell lines are used in more drug discovery studies.

Therefore, owing to all the aforementioned advantages associated with systems, it is expected to drive the demand for systems, thereby propelling the overall market for Automated cell culture during the forecast period from 2024 to 2030.

North America Is Expected To Dominate The Overall Automated Cell Culture Market:

North America is expected to account for the highest proportion of the Automated Cell Culture Market in 2023, out of all regions. This is due to the presence of a large patient population base in North America associated with several diseases such as cancers, and asthma, among others. In addition, the growing focus on R&D activities by key manufacturers, and rising clinical and research initiatives associated with automated cell cultures in the region are factors responsible for the growth of the North America Automated Cell Culture market.

As per data by the National Center for Health Statistics (2022), nearly 26 million people in the U.S. have asthma; equal to about 1 in 13 people. The source further stated that nearly 21 million U.S. adults aged 18 and older have asthma, with asthma being more common in female adults than male adults. The rising incidence of cancers in the US such as lung cancer is also expected to drive the market demand for automated cell cultures. As per data by the Centers for Disease Control and Prevention (2023), 197,453 new lung cancers were reported in the US in 2020, also with 136,084 cases of deaths resulting from lung cancer in the same year.

Moreover, the market is growing as a result of the developing biotechnology sector, better cell culture technology systems, and an increased need for cell culture technology in the production of vaccines, in the US. Also, medical research is supported by the US government since healthcare is one of the main goals in the United States. In 2023, Molecular Devices launched AI-powered system CellXpress.ai automated cell culture system which offers features like automated passaging, analysis of image feeding, and data managing for efficient cell culture workflows.

In addition, the United States represents the largest market worldwide supported by developed healthcare infrastructure and strong adoption of technologically advanced products owing to rise in the healthcare expenditure by the US government. Thus, the interplay of all the aforementioned factors are likely to fuel the regional market in North America for automated cell culture during the forecasted period.

Automated Cell Culture Market Key Players:

Some of the key market players operating in the Automated Cell Culture market include Thermofisher Scientific Inc., DH Life Sciences, LLC., Molecular Devices, LLC., Merck KGaA, Lonza Group AG, Sartorius AG, Cytocentric, Corning Incorporated, Agilent Technologies Inc., Cytiva, CYTENA GmbH, FORMULATRIX, Nucleus Biologics, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., FUJIFILM Corporation, Nikon Corporation, Hamilton Company, Brooks Automation, Inc., Tecan Trading AG, and others.

Recent Developmental Activities In The Automated Cell Culture Market:

• In February 2023, ThermoFisher Scientific and Celltrio announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers. The collaboration integrated the ThermoScientific Momentum workflow scheduling software with the Celltrio RoboCell cell line automation platform to address the unmet market need for high-throughput automated cell line culturing and maintenance.
• In March 2022, Cellink launched BIO CELLX, which is a first of its kind biodispensing platform used to automate 3D cell culture. It provides cell biologists with pre-validated protocols, and eliminates barriers for automating 3D cell-based assays that target cancer research and drug discovery.
• In August 2021, Amerigo Scientific, a company focused on providing critical products and services to the biomedical and life science research communities, expanded its cell culture portfolio with the launch of 3D Cell Culture for scientific uses. The new 3D cell culture system could be used in research areas such as drug discovery, medicine, evaluation of nanomaterials, and basic life science.

Key Takeaways From The Automated Cell Culture Market Report Study

• Market size analysis for current Automated Cell Culture Market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product offerings, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Automated Cell Culture market.
• Various opportunities available for the other competitors in the Automated Cell Culture Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Automated Cell Culture market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Automated Cell Culture market growth in the coming future?

Target Audience Who Can Be Benefited From This Automated Cell Culture Market Report Study

• Automated Cell Culture product providers
• Public and Private Corporate companies
• Automated Cell Culture-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Product Providers dealing in Automated Cell Culture
• Various corporates who want to know more about the Automated Cell Culture Market and the latest product offerings in the Automated Cell Culture Market.

Frequently Asked Questions For The Automated Cell Culture Market:

1. What are Automated Cell Culture?

Automated Cell Culture are medical devices that convert liquids into aerosols which are then easily transported to the lower respiratory tract. These are commonly used as bronchodilators and help in the treatment of patients suffering from respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory diseases.

2. What is the market for Automated Cell Culture?

The global automated cell culture market is estimated to grow at a CAGR of 7.17% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Automated Cell Culture market?

The Automated Cell Culture Market is slated to witness prosperity owing to the increasing funding for cell-based research, technological advancements in cell culture, and the growing focus on regenerative medicine, among others during the forecast period from 2024 to 2030.

4. Who are the key players operating in the global Automated Cell Culture market?

Some of the key market players operating in the Automated Cell Culture market include Thermofisher Scientific Inc., DH Life Sciences, LLC., Molecular Devices, LLC., Merck KGaA, Lonza Group AG, Sartorius AG, Cytocentric, Corning Incorporated, Agilent Technologies Inc., Cytiva, CYTENA GmbH, FORMULATRIX, Nucleus Biologics, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., FUJIFILM Corporation, Nikon Corporation, Hamilton Company, Brooks Automation, Inc., Tecan Trading AG, and others.

5. Which region has the highest share in the Global Automated Cell Culture market?

North America is expected to dominate the overall Automated Cell Culture market during the forecast period from 2024 to 2030. This is due to the presence of a large patient population base in North America associated with several diseases such as cancers, and asthma, among others. In addition, the growing focus on R&D activities by key manufacturers, and rising clinical and research initiatives associated with automated cell cultures in the region are factors responsible for the growth of the North America Automated Cell Culture market.


This product will be delivered within 2 business days.